Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
9 pending office actions • 5 art units • 7 examiners • 0 of 9 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
LifeCell Corporation has 9 pending office actions in Biotechnology & Pharmaceuticals. Examination is distributed across 7 examiners and 5 art units, so the portfolio requires coordination across multiple examination channels rather than a single recurring assignment.
BARIA, DINAH N is the busiest examiner, with 2 pending matters. That figure is less than the portfolio total, showing that no single examiner controls the full workload. Counsel should track examiner-specific issues while maintaining an art-unit-level view of prosecution strategy.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (11%) |
| Double-patenting only | 1 (11%) |
| Double-patenting + other | 4 (44%) |
| Multi-statute (no §101) | 3 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BARIA, DINAH N | 2 | 72.9% | +28.5% |
| FOX, ALLISON M | 2 | 71.0% | +35.7% |
| PALLAY, MICHAEL B | 1 | 55.8% | +33.8% |
| LIU, TRACY | 1 | 54.5% | +26.9% |
| JOHNSON, KARA D | 1 | 69.3% | +25.1% |
| GHERBI, SUZETTE JAIME J | 1 | 85.1% | +8.7% |
| SAEED, ALI S | 1 | 31.6% | +33.8% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18783873 | BREAST PROSTHESES, METHODS OF MANUFACTURING BREAST PROSTHESES, AND METHODS OF TREATMENT USING BREAST PROSTHESES | GHERBI, SUZETTE JAIME J | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18819281 | TISSUE MATRIX MATERIALS AND ENZYMATIC ADHESIVES | JOHNSON, KARA D | — |
| 18792639 | COMPOSITE TISSUE PRODUCT ANCHOR BOLSTER FOR THREE-DIMENSIONAL BIOLOGIC SCAFFOLDS AND RELATED METHODS | BARIA, DINAH N | — |
| 18583308 | DECELLULARIZED MUSCLE MATRIX | FOX, ALLISON M | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 16894261 | COATED POLYMERIC MATERIAL | SAEED, ALI S | 56d |
| 19028767 | ADIPOSE TISSUE MATRICES | PALLAY, MICHAEL B | — |
| 18922885 | NATURAL TISSUE SCAFFOLDS AS TISSUE FILLERS | LIU, TRACY | — |
| 18819281 | TISSUE MATRIX MATERIALS AND ENZYMATIC ADHESIVES | JOHNSON, KARA D | — |
| 18792639 | COMPOSITE TISSUE PRODUCT ANCHOR BOLSTER FOR THREE-DIMENSIONAL BIOLOGIC SCAFFOLDS AND RELATED METHODS | BARIA, DINAH N | — |
| 18641818 | PERFORATED TISSUE MATRIX | BARIA, DINAH N | — |
| 18583308 | DECELLULARIZED MUSCLE MATRIX | FOX, ALLISON M | — |
| 18386832 | METHODS FOR MAKING ACELLULAR TISSUE MATRICES | FOX, ALLISON M | — |
| Art Unit | Apps |
|---|---|
| 3774 | 4 |
| 1633 | 2 |
| 1614 | 1 |
| 1632 | 1 |
| 1616 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19028767 | ADIPOSE TISSUE MATRICES | PALLAY, MICHAEL B | 3774 | §112DP | Non-Final OA | — | Pending | Jan 17, 2025 |
| 18922885 | NATURAL TISSUE SCAFFOLDS AS TISSUE FILLERS | LIU, TRACY | 1614 | §103§112DP | Non-Final OA | — | Pending | Oct 22, 2024 |
| 18819281 | TISSUE MATRIX MATERIALS AND ENZYMATIC ADHESIVES | JOHNSON, KARA D | 1632 | §102§103§112 | Non-Final OA | — | Pending | Aug 29, 2024 |
| 18792639 | COMPOSITE TISSUE PRODUCT ANCHOR BOLSTER FOR THREE-DIMENSIONAL BIOLOGIC SCAFFOLDS AND RELATED METHODS | BARIA, DINAH N | 3774 | §102§103 | Non-Final OA | — | Pending | Aug 02, 2024 |
| 18783873 | BREAST PROSTHESES, METHODS OF MANUFACTURING BREAST PROSTHESES, AND METHODS OF TREATMENT USING BREAST PROSTHESES | GHERBI, SUZETTE JAIME J | 3774 | DP | Non-Final OA | — | Pending | Jul 25, 2024 |
| 18641818 | PERFORATED TISSUE MATRIX | BARIA, DINAH N | 3774 | §103§112DP | Non-Final OA | — | Pending | Apr 22, 2024 |
| 18583308 | DECELLULARIZED MUSCLE MATRIX | FOX, ALLISON M | 1633 | §102§103 | Non-Final OA | — | Pending | Feb 21, 2024 |
| 18386832 | METHODS FOR MAKING ACELLULAR TISSUE MATRICES | FOX, ALLISON M | 1633 | §112Other | Non-Final OA | — | Pending | Nov 03, 2023 |
| 16894261 | COATED POLYMERIC MATERIAL | SAEED, ALI S | 1616 | §103§112DP | Non-Final OA | 56d | Pending | Jun 05, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialLifeCell Corporation has 9 pending office actions as of October 2026, spread across 5 art units and 7 examiners.
Dinah N Baria has the most, with 2 of LifeCell Corporation's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
